Alerts will be sent to your verified email
Verify Email
WELCURE
|
Welcure Drugs&Pharma
|
IFL Enterprises
|
Bizotic Commercial
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
58.66 % | 0.64 % | 39.45 % |
|
5yr average Equity Multiplier
|
-0.69 | 1.09 | 20.92 |
|
5yr Average Asset Turnover Ratio
|
0.59 | 0.27 | 1.11 |
|
5yr Avg Net Profit Margin
|
-73.67 % | 0.66 % | 2.63 % |
|
Price to Book
|
1.49 | 1.88 | 0.0 |
|
P/E
|
70.39 | 49.1 | 38.86 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 174.75 Days | 102.27 Days |
|
Inventory Days
|
20.66 Days | 25.92 Days | 103.17 Days |
|
Days Receivable
|
1232.42 Days | 209.71 Days | 133.42 Days |
|
Days Payable
|
0.0 | 32.45 Days | 218.59 Days |
|
5yr Average Interest Coverage Ratio
|
-2.67 | 176.72 | 15.03 |
|
5yr Avg ROCE
|
8.46 % | 1.49 % | 29.16 % |
|
5yr Avg Operating Profit Margin
|
-73.54 % | -31.83 % | 3.09 % |
|
5 yr average Debt to Equity
|
-0.59 | 0.0 | 1.32 |
|
5yr CAGR Net Profit
|
-37.48 % | n/a | 80.67 % |
|
5yr Average Return on Assets
|
13.61 % | 0.44 % | 2.89 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 0.0 | 70.0 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-14.12 % | -3.67 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Welcure Drugs&Pharma
|
IFL Enterprises
|
Bizotic Commercial
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|